DiaMedica Therapeutics (DMAC) Gains from Investment Securities (2018)
DiaMedica Therapeutics (DMAC) posted quarterly Gains from Investment Securities of $39000.0 for Q1 2018.
DiaMedica Therapeutics (DMAC) Gains from Investment Securities (2018) Analysis & Trends
DiaMedica Therapeutics' Gains from Investment Securities history runs 1 years deep, the most recent figure standing at $39000.0 for Q1 2018.
- In Q1 2018, Gains from Investment Securities changed N/A year-over-year to $39000.0; the TTM figure through Dec 2018 stood at $39000.0 (changed N/A YoY), while the FY2018 annual figure was $39000.0, up 533.33% from the prior year.
- Gains from Investment Securities for Q1 2018 stood at $39000.0.
- The five-year high for Gains from Investment Securities was $39000.0 in Q1 2018, with the low at $39000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 39,000.00 |
| Mar 31, 2018 | 39,000.00 |